CD274 and neoplasm: Tumors with a combined positive score (CPS), i.e., the combined scoring of PD-L1-expressing tumor cells (TCs) and all immune cells (ICs), of ≥20, and to a lesser extent ≥1, have an increased objective response rate and post-therapy survival [6,7,8,9,10].